TALIS BIOMEDICAL CORP - COM (TLIS)

CUSIP: 87424L108

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
13,715,030
Share change
-1,213,987
Total reported value
$151,277,000
Price per share
$11.03
Number of holders
42
Value change
-$14,668,209
Number of buys
18
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 87424L108?
CUSIP 87424L108 identifies TLIS - TALIS BIOMEDICAL CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TALIS BIOMEDICAL CORP - COM (TLIS) as of Q2 2021

As of 30 Jun 2021, TALIS BIOMEDICAL CORP - COM (TLIS) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,715,030 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BOXER CAPITAL, LLC, Nicholas Investment Partners, LP, BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, Redmile Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 42 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.